J Neurol Surg A Cent Eur Neurosurg
DOI: 10.1055/s-0044-1782141
Review Article

Subdural Hematoma due to Dural Metastasis: A Systematic Review on Frequency, Clinical Characteristics, and Neurosurgical Management

1   University College of Medical Sciences and Guru Teg Bahadur Hospital, Delhi, India
,
1   University College of Medical Sciences and Guru Teg Bahadur Hospital, Delhi, India
,
Atulya Chandra
1   University College of Medical Sciences and Guru Teg Bahadur Hospital, Delhi, India
,
Joe M. Das
2   Department of Neurosurgery, Salford Royal Hospital, Salford, United Kingdom
› Author Affiliations
Funding None.

Abstract

Background Subdural hematoma (SDH) occasionally accompanies dural metastasis and is associated with high recurrence rate, significantly impacting patient morbidity and mortality. This systematic review aims to evaluate the characteristics, management options, and outcomes of patients with SDH associated with dural metastasis.

Methods A comprehensive search of the PubMed and Cochrane databases was conducted for English-language studies published from inception to March 20, 2023, adhering to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. The authors reviewed cases of histopathologically confirmed SDH with non-central nervous system (non-CNS) tumor metastasis, focusing on therapeutic management of SDH. Statistical analysis was performed using SPSS software, with a significance level set at 0.05.

Results This review included 32 studies comprising 37 patients with 43 SDH cases associated with dural metastasis. Chronic SDH was the most frequently observed presentation (n = 28, 65.12%). The systemic malignancies most commonly associated with SDH due to dural metastasis were prostate carcinoma (n = 9, 24.32%) and gastric carcinoma (n = 5, 13.51%). A statistically significant association was found between metastatic melanoma and subacute SDH (p = 0.010). The majority of patients were treated with burr holes (n = 15, 40.54%) or craniotomies (n = 14, 37.84%), with no statistically significant difference in mortality rates between the two techniques (p = 0.390). Adjuvant therapy was administered to a limited number of patients (n = 5, 13.51%), including chemotherapy (n = 2, 5.41%), whole brain radiotherapy (n = 1, 2.70%), a combination of chemotherapy and whole brain radiotherapy (n = 1, 2.70%), and transcatheter arterial chemoembolization (n = 1, 2.70%). The overall recurrence rate was 45.95% (n = 17), with burr holes being the most common management approach (n = 4, 10.81%). Within a median of 8 days, 67.57% (n = 25) of patients succumbed, primarily due to rebleeding (n = 3, 8.11%), disseminated intravascular coagulation (n = 3, 8.11%), and pneumonia (n = 3, 8.11%).

Conclusion This review highlights the need for improving existing neurosurgical options and exploring novel treatment methods. It also emphasizes the importance of dural biopsy in patients with suspected metastasis to rule out a neoplastic etiology.



Publication History

Received: 23 June 2023

Accepted: 20 December 2023

Article published online:
04 March 2024

© 2024. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References

  • 1 Laigle-Donadey F, Taillibert S, Mokhtari K, Hildebrand J, Delattre JY. Dural metastases. J Neurooncol 2005; 75 (01) 57-61
  • 2 Meyer PC, Reah TG. Secondary neoplasms of the central nervous system and meninges. Br J Cancer 1953; 7 (04) 438-448
  • 3 Posner JB. Neurologic Complications of Cancer. 1st ed.. Oxford: Oxford University Press; 1995: 77-82
  • 4 Caputi F, Lamaida E, Gazzeri R. Acute subdural hematoma and pachymeningitis carcinomatosa: case report. Rev Neurol (Paris) 1999; 155 (05) 383-385
  • 5 Ambiavagar PC, Sher J. Subdural hematoma secondary to metastatic neoplasm: report of two cases and a review of the literature. Cancer 1978; 42 (04) 2015-2018
  • 6 Bergmann M, Puskas Z, Kuchelmeister K. Subdural hematoma due to dural metastasis: case report and review of the literature. Clin Neurol Neurosurg 1992; 94 (03) 235-240
  • 7 Leech RW, Welch FT, Ojemann GA. Subdural hematoma secondary to metastatic dural carcinomatosis. Case report. J Neurosurg 1974; 41 (05) 610-613
  • 8 Bucci MN, Farhat SM. Metastatic adenocarcinoma of the prostate as a cause of subdural hematoma. J Urol 1986; 135 (04) 803-804
  • 9 Cheng CL, Greenberg J, Hoover LA. Prostatic adenocarcinoma metastatic to chronic subdural hematoma membranes. Case report. J Neurosurg 1988; 68 (04) 642-644
  • 10 Vasudev Rao T, Deshpande DH. Malignant subdural effusion. A case report. Acta Neurochir (Wien) 1980; 52 (1-2): 61-65
  • 11 Alsahan A, Alobaid M, Aldukhayyil T, Alfaraj D. Subacute bilateral subdural hematoma: delayed presentation with headache one month post mild trauma. Cureus 2021; 13 (11) e19183
  • 12 Bullock MR, Chesnut R, Ghajar J. et al; Surgical Management of Traumatic Brain Injury Author Group. Surgical management of acute subdural hematomas. Neurosurgery 2006; 58 (3, Suppl): S16-S24 , discussions i-iv
  • 13 Jayawant S, Rawlinson A, Gibbon F. et al. Subdural haemorrhages in infants: population based study. BMJ 1998; 317 (7172) 1558-1561
  • 14 Hobbs C, Childs AMM, Wynne J, Livingston J, Seal A. Subdural haematoma and effusion in infancy: an epidemiological study. Arch Dis Child 2005; 90 (09) 952-955
  • 15 Russell DS, Cairns H. Subdural false membrane or hematoma (pachymeningitis interna haemorrhagica) in carcinomatosis and sarcomatosis of the duramater. Bruin 1934; 57: 32-48
  • 16 Braun EM, Burger LJ, Schlang HA. Subdural hematoma from metastatic malignant disease. Cancer 1973; 32 (06) 1370-1373
  • 17 Castleman B, Scully RE, McNeely BU. Presentation of case 12–1972. N Engl J Med 1972; 286: 650-656
  • 18 Mirsadeghi SMH, Habibi Z, Meybodi KT, Nejat F, Tabatabai SAF. Malignant subdural effusion associated with disseminated adenocarcinoma: a case report. Cases J 2008; 1 (01) 328
  • 19 Westenhoeffer M. Pachymeningitis carcinomatosa haemorrhagica interna productiva mit Colibacillosis agonalis. Virchows Arch 1904; 175: 364-379
  • 20 Katsube T, Kikuchi T, Konnno S. et al. Subdural hematoma associated with dural metastasis of gastric carcinoma: report of two cases. Anticancer Res 2007; 27 (6C): 4339-4344
  • 21 Ashish K, Das K, Mehrotra A. et al. Intracranial dural metastasis presenting as chronic subdural hematoma: a case report and review of literature. Turk Neurosurg 2014; 24 (06) 992-995
  • 22 Fukino K, Terao T, Kojima T, Adachi K, Teramoto A. Chronic subdural hematoma following dural metastasis of gastric cancer: measurement of pre- and postoperative cerebral blood flow with N-isopropyl-p-[123I]iodoamphetamine: case report. Neurol Med Chir (Tokyo) 2004; 44 (12) 646-649
  • 23 Oshita J, Ohba S, Itou Y, Yonezawa K, Hosogai M. Metastasis of hepatocellular carcinoma to the membrane of chronic subdural hematomas: a case report. No Shinkei Geka 2017; 45 (10) 905-911
  • 24 Ikeda H, Nakajima N, Terashima T, Kawabata Y, Miyake H, Miyamoto S. Repeated short-term recurrence of chronic subdural hematoma associated with metastasis to hematoma capsule originating from extracranial malignant tumor. World Neurosurg 2018; 111: 201-206
  • 25 Koç RK, Akdemir H, Oktem IS, Meral M, Menkü A. Acute subdural hematoma: outcome and outcome prediction. Neurosurg Rev 1997; 20 (04) 239-244
  • 26 Dent DL, Croce MA, Menke PG. et al. Prognostic factors after acute subdural hematoma. J Trauma 1995; 39 (01) 36-42 , discussion 42–43
  • 27 Servadei F, Nasi MT, Giuliani G. et al. CT prognostic factors in acute subdural haematomas: the value of the ‘worst’ CT scan. Br J Neurosurg 2000; 14 (02) 110-116
  • 28 Massaro F, Lanotte M, Faccani G, Triolo C. One hundred and twenty-seven cases of acute subdural haematoma operated on. Correlation between CT scan findings and outcome. Acta Neurochir (Wien) 1996; 138 (02) 185-191
  • 29 Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018; 68 (06) 394-424
  • 30 Black DW. Subdural hematoma. A retrospective study of the “great neurologic imitator.”. Postgrad Med 1985; 78 (01) 107-111 , 114
  • 31 Taylor LP. Mechanism of brain tumor headache. Headache 2014; 54 (04) 772-775
  • 32 Cohen DS, Quest DO. Increased intracranial pressure, brain herniation, and their control. In: Willkins RH, Rengachary SS. eds. Neurosurgery. 2nd ed.. New York, NY: McGraw-Hill Health Professional Division; 1996: 345-356
  • 33 Diamond S. Head pain. Diagnosis and management. Clin Symp 1994; 46 (03) 2-34
  • 34 Schwartz H, Blacher E, Amer M. et al. Incipient melanoma brain metastases instigate astrogliosis and neuroinflammation. Cancer Res 2016; 76 (15) 4359-4371
  • 35 Soo WT, Teo EG, Mohamad N, Wong ASH. Chronic subdural hematoma caused by calvarial and dural metastasis from uterine leiomyosarcoma. J Neurosci Rural Pract 2022; 13 (02) 351-353
  • 36 Kosaka T, Ikeda N, Furuse M. et al. Refractory chronic subdural hematoma associated with dural metastasis of lung adenocarcinoma treated with endovascular embolization for the middle meningeal artery: a case report and review of the literature. World Neurosurg 2020; 133: 256-259
  • 37 Kurzaj E, Kopczynski S, Barowska-Lehman J, Ludwiczak R. Subdural haematoma associated with dural carcinomatosis in a patient with primary carcinoma of pancreas. Neurochirurgia (Stuttg) 1980; 23 (01) 13-17
  • 38 Vonofakos D, Zieger A, Marcu H. Subdural hematoma associated with dural metastatic tumor. Neuroradiology 1980; 20 (04) 213-218
  • 39 Turner DM, Graf CJ. Nontraumatic subdural hematoma secondary to dural metastasis: case report and review of the literature. Neurosurgery 1982; 11 (05) 678-680
  • 40 Nagayama I, Katoh H, Sakumoto M, Itoh M, Yoshida K. Subdural hematoma associated with dural metastasis from paranasal sinus cancer: a case report and review of the literature. ORL J Otorhinolaryngol Relat Spec 1993; 55 (04) 240-243
  • 41 Cross PA, Ortega LG, Thedore N, Wadleigh RG. A subdural hematoma from metastatic esophageal cancer. Acta Oncol 1995; 34 (04) 538-540
  • 42 Lecouvet FE, Annet L, Duprez TP, Cosnard G, Scordidis V, Malghem J. Uncommon magnetic resonance imaging observation of lumbar subdural hematoma with cranial origin. J Comput Assist Tomogr 2003; 27 (04) 530-533
  • 43 Tseng SH, Liao CC, Lin SM, Chen Y, Shun CT. Dural metastasis in patients with malignant neoplasm and chronic subdural hematoma. Acta Neurol Scand 2003; 108 (01) 43-46
  • 44 Kunii N, Morita A, Yoshikawa G, Kirino T. Subdural hematoma associated with dural metastasis: case report. Neurol Med Chir (Tokyo) 2005; 45 (10) 519-522
  • 45 Comănescu A, Roşca E, Bota M, Ninulescu G. Chronic subdural hematoma in a patient with acute myeloid leukemia and dural metastatic infiltration. Rom J Morphol Embryol 2008; 49 (02) 259-262
  • 46 Dorsi MJ, Zenonos G, Hsu W, Huang J. Dural prostate adenocarcinoma metastasis with subdural hematoma mimicking the appearance of an epidural hematoma. Clin Neurol Neurosurg 2010; 112 (06) 501-504
  • 47 Zheng JX, Tan TK, Kumar DS, Lim LC, Loh HL. Subdural haematoma due to dural metastases from bronchogenic carcinoma in a previously well patient: an unusual cause of non-traumatic recurrent intracranial haematomata. Singapore Med J 2011; 52 (04) e66-e69
  • 48 George KJ, Lau A, Ellis M, Kiehl TR, Fehlings MG. Metastatic coagulopathic subdural hematoma: a dismal prognosis. Surg Neurol Int 2012; 3: 60
  • 49 Prasad BC, Chandra VV, Varaprasad G. Dural metastases in chronic myeloid leukemia presenting as subdural hematoma. Turk Neurosurg 2012; 22 (06) 777-778
  • 50 O'Meara C, Mahasneh T, Wilson P, I'Ons B, Alkhawaja D. Dural prostate metastasis resembling a chronic subdural haematoma. J Surg Case Rep 2012; 2012 (05) 7
  • 51 Kuan-Yin T, Dueng-Yuan H, Hsin-I M. Subdural hematoma associated with skull and dural metastasis of gastric carcinoma: a case report. Turk Neurosurg 2013; 23 (06) 796-799
  • 52 Yuan X, Zhao H, Zhao C. et al. Chronic subdural hematoma due to dural metastasis of gastric adenocarcinoma progressing rapidly with uncal herniation. J Craniofac Surg 2014; 25 (06) 2270-2272
  • 53 Chye CL, Lin KH, Ou CH, Sun CK, Chang IW, Liang CL. Acute spontaneous subdural hematoma caused by skull metastasis of hepatocellular carcinoma: case report. BMC Surg 2015; 15: 60
  • 54 Onen MR, Kayalar AE, Haciyakupoglu E, Tosun I, Kir G, Naderi S. Dural prostate metastasis presenting as a subdural hematoma. North Clin Istanb 2017; 4 (03) 279-282
  • 55 Knieling A, Diac MM, Rişcanu LA, Zăvoi RE, Bulgaru Iliescu D. Subdural hematoma: a cause of death in the development of a prostatic adenocarcinoma with dural metastases: case report. Rom J Morphol Embryol 2017; 58 (04) 1549-1553
  • 56 Kosugi K, Takahashi S, Sasaki H, Tamura R, Ohara K, Yoshida K. A case of acute subdural hematoma due to bleeding from metastatic chondrosarcoma of the skull. Surg Neurol Int 2017; 8: 23
  • 57 Lippa L, Cerase A, Cecconi F, Cacciola F. Post-traumatic acute-on-chronic subdural haematoma: an unusual presentation of skull metastasis from prostate carcinoma. BMJ Case Rep 2017; 2017: bcr2017221187
  • 58 Abunimer AM, Abou-Al-Shaar H, White TG, Li JY, Chalif DJ. Metastatic subdural hematoma with dural metastasis secondary to poorly differentiated adenocarcinoma of unknown origin. World Neurosurg 2019; 125: 343-346
  • 59 Armocida D, Marzetti F, Pesce A, Caporlingua A, D'Angelo L, Santoro A. Purely meningeal intracranial relapse of melanoma brain metastases after surgical resection and immunotherapy as a unique disease progression pattern: our experience and review of the literature. World Neurosurg 2020; 134: 150-154
  • 60 Yamaguchi I, Kanematsu Y, Mizobuchi Y. et al. Chronic subdural hematoma associated with dural metastasis leads to early recurrence and death: a single-institute, retrospective cohort study. J Clin Neurosci 2021; 94: 244-249
  • 61 Kinjo T, Sakurai Y, Ogawa A, Komatsu S, Suzuki J. Nonsurgical treatment of chronic subdural hematoma. Sequential changes of computed tomography findings. Neurol Med Chir (Tokyo) 1985; Aug; 25 (08) 645-653